Home Duke University Press
QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

First published on April 9, 2008
This version was published on January 1, 2008
Neuro Oncol 2008 10(3):361-367; DOI:10.1215/15228517-2008-008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
10/3/361    most recent
15228517-2008-008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandes, A. A.
Right arrow Articles by Franceschi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Review

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

Alba A. Brandes, Alicia Tosoni, Federica Spagnolli, Giampiero Frezza, Marco Leonardi, Fabio Calbucci and Enrico Franceschi

Departments of Medical Oncology (A.A.B., A.T., E.F.), Radiotherapy (F.S., G.F.), Neuroradiology (M.L.), and Neurosurgery (F.C.), Bellaria-Maggiore Hospital, AUSL Bologna, Bologna, Italy

Address correspondence to Alba A. Brandes, Department of Medical Oncology, Azienda USL Bellaria-Maggiore, Bologna, Italy (alba.brandes{at}yahoo.it).

Although radionecrosis has been exhaustively described in depth in the neurooncological literature, its diagnosis is still a challenging issue because its radiological pattern is frequently indistinguishable from that of tumor recurrence. This review discusses the causes of radionecrosis and the potential effect of adjuvant chemotherapy concomitant with radiotherapy on its rate and onset. The potential pitfalls in clinical studies attempting to make a differential diagnosis between radionecrosis and disease progression are also discussed.

Key Words: chemotherapy • glioma • pseudoprogression • radionecrosis • radiotherapy




This article has been cited by other articles:


Home page
 JCOHome page
A. A. Brandes, E. Franceschi, and A. Tosoni
In Reply
J. Clin. Oncol., September 10, 2008; 26(26): 4359 - 4360.
[Full Text] [PDF]


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2008 by Society for Neuro-Oncology